ClinicalTrials.Veeva

Menu

Feeding Tolerance Evaluation

N

Nestlé

Status

Completed

Conditions

Healthy

Treatments

Other: infant formula

Study type

Interventional

Funder types

Industry

Identifiers

NCT02405572
14.32.US.INF

Details and patient eligibility

About

Crossover study of 2 infant formulas

Full description

Exclusively formula-fed infants will participate in two 2-week feeding periods of 2 infant formulas. Daily tolerance records will be kept by caregivers.

Enrollment

43 patients

Sex

All

Ages

Under 2 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy newborn infant
  • Full-term (> 37 weeks gestation)
  • 0-2 months (birth-56 days) of age on enrollment
  • Infant exclusively formula-fed for at least 2 days prior to enrollment
  • Having obtained his/her legal representative's informed consent

Exclusion criteria

  • Known or suspected cow-milk allergy
  • Congenital illness or malformation
  • Significant prenatal and/or postnatal disease
  • Currently participating in another clinical study

Trial design

43 participants in 2 patient groups

Formula 1
Active Comparator group
Description:
infant formula
Treatment:
Other: infant formula
Formula 2
Active Comparator group
Description:
infant formula
Treatment:
Other: infant formula

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems